NCT07003906 Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy
| NCT ID | NCT07003906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uppsala University |
| Condition | Surgical Incision |
| Study Type | INTERVENTIONAL |
| Enrollment | 720 participants |
| Start Date | 2025-12-16 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 720 participants in total. It began in 2025-12-16 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate Negative Pressure Wound Therapy (NPWT) in adults undergoing emergency laparotomy. The main question it aims to answer is: Does NPWT decrease wound complications? Researchers will compare it against regular dressings to see if NPWT is superior.
Eligibility Criteria
Inclusion Criteria: * ≥18 years old * Written informed consent * \>10 cm midline incision with primary skin closure * Emergency laparotomy Exclusion Criteria: * Not able to consent (e.g. dementia, impaired cognitive function, unconscious) * Subjects not possible to follow up as assessed by the Investigator * Allergy to dressing material * Pregnancy or breastfeeding (females of childbearing potential) * Previous enrolment in the current study * Expected reoperation with 28 days of index laparotomy * Emergency laparotomy within 3 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07003906 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Surgical Incision. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07003906 currently recruiting?
Yes, NCT07003906 is actively recruiting participants. Contact the research team at erik.osterman@akademiska.se for enrollment information.
Where is the NCT07003906 trial being conducted?
This trial is being conducted at Eskilstuna, Sweden, Linköping, Sweden, Mora, Sweden, Norrköping, Sweden and 2 additional locations.
Who is sponsoring the NCT07003906 clinical trial?
NCT07003906 is sponsored by Uppsala University. The trial plans to enroll 720 participants.